Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
1.
Brain Res ; 1516: 33-44, 2013 Jun 21.
Article in English | MEDLINE | ID: mdl-23623775

ABSTRACT

The effects of a prolonged seizure, i.e. status epilepticus (SE), on neurogenesis of dentate granule cells (DGCs) in the immature dentate gyrus (DG) and possible changes in the phenotypes of the newborn neurons have remained incompletely characterized. We have now studied neurogenesis of DGCs in 9-day-old (postnatal, P9) rats 1 week after kainate (KA)-induced SE using 5-bromo-2-deoxyuridine (BrdU) immunostaining. The phenotype characterization of the newborn cells was carried out by immunofluorescence double labeling using doublecortin (DCX) and nestin as markers for immature cells, and glial fibrillary acid protein (GFAP) as a marker for glial cells. Newborn GABAergic neurons were further identified with antibodies for parvalbumin, glutamate decarboxylase 67 (GAD67), and the GABAA receptor α1 subunit, and mRNA expression of GABAergic and immature neurons was measured with quantitative real-time PCR (qPCR) in the DG. Our results show that the number of newborn as well as GABAergic neurons was significantly decreased after SE in the superior blade of the septal DG. The majority of the newborn BrdU-stained neurons co-expressed DCX, but neither nestin nor GFAP. In both experimental groups, newborn neurons were frequently localized in close contact, but not co-localized, with the cells positively stained for the GABAergic cell markers. Nestin and calretinin mRNA expression were significantly increased after SE. Our results suggest that SE-induced disruption of DGC neurogenesis and decreased number of GABAergic neurons could modify the connectivity between these cells and disturb the maturation of the GABAergic neurotransmission in the immature DG at the early epileptogenic phase.


Subject(s)
Dentate Gyrus/pathology , Epilepsy/pathology , Epilepsy/physiopathology , GABAergic Neurons/pathology , Neurogenesis/physiology , Animals , Animals, Newborn , Bromodeoxyuridine/metabolism , Cell Count , Disease Models, Animal , Doublecortin Protein , Epilepsy/chemically induced , Excitatory Amino Acid Agonists/toxicity , Gene Expression Regulation/drug effects , Glutamate Decarboxylase/genetics , Glutamate Decarboxylase/metabolism , Kainic Acid/toxicity , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neurogenesis/drug effects , Parvalbumins/genetics , Parvalbumins/metabolism , Rats , Receptors, GABA-A/genetics , Receptors, GABA-A/metabolism
2.
Neuroscience ; 146(2): 802-11, 2007 May 11.
Article in English | MEDLINE | ID: mdl-17360122

ABSTRACT

GABA, the main inhibitory neurotransmitter in the adult brain, exerts its effects through multiple GABA(A) receptor subtypes with different pharmacological profiles, the alpha subunit variant mainly determining the binding properties of benzodiazepine site on the receptor protein. In adult experimental epileptic animals and in humans with epilepsy, increased excitation, i.e. seizures, alters GABA(A) receptor subunit expression leading to changes in the receptor structure, function, and pharmacology. Whether this also occurs in the developing brain, in which GABA has a trophic, excitatory effect, is not known. We have now applied autoradiography to study properties of GABA(A)/benzodiazepine receptors in 9-day-old rats acutely (6 h) and sub-acutely (7 days) after kainic acid-induced status epilepticus by analyzing displacement of [(3)H]flunitrazepam binding by zolpidem, a ligand selective for the alpha1beta2gamma2 receptor subtype. Regional changes in the binding properties were further corroborated at the cellular level by immunocytochemistry. The results revealed that status epilepticus significantly decreased displacement of [(3)H]flunitrazepam binding by zolpidem 6 h after the kainic acid-treatment in the dentate gyrus of the hippocampus, parietal cortex, and thalamus, and in the hippocampal CA3 and CA1 cell layers 1 week after the treatment. Our results suggest that status epilepticus modifies region-specifically the pharmacological properties of GABA(A) receptors, and may thus disturb the normal, strictly developmentally-regulated maturation of zolpidem-sensitive GABA(A) receptors in the immature rat brain. A part of these changes could be due to alterations in the cell surface expression of receptor subtypes.


Subject(s)
Brain , Flunitrazepam/pharmacokinetics , GABA Agonists/pharmacology , GABA Modulators/pharmacokinetics , Pyridines/pharmacology , Status Epilepticus/pathology , Age Factors , Analysis of Variance , Animals , Animals, Newborn , Autoradiography/methods , Brain/drug effects , Brain/growth & development , Brain/metabolism , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Interactions , Kainic Acid , Protein Binding/drug effects , Pyridines/therapeutic use , Rats , Rats, Sprague-Dawley , Receptors, GABA-A/metabolism , Status Epilepticus/chemically induced , Zolpidem
3.
J Neurochem ; 94(5): 1384-94, 2005 Sep.
Article in English | MEDLINE | ID: mdl-15992369

ABSTRACT

Kainic acid-induced status epilepticus leads to structural and functional changes in inhibitory GABAA receptors in the adult rat hippocampus, but whether similar changes occur in the developing rat is not known. We have used in situ hybridization to study status epilepticus-induced changes in the GABAAalpha1-alpha5, beta1-beta3, gamma1 and gamma2 subunit mRNA expression in the hippocampus of 9-day-old rats during 1 week after the treatment. Immunocytochemistry was applied to detect the alpha1, alpha2 and beta3 subunit proteins in the control and treated rats. In the saline-injected control rats, the alpha1 and alpha4 subunit mRNA expression significantly increased between the postnatal days 9-16, whereas those of alpha2, beta3 and gamma2 subunits decreased. The normal developmental changes in the expression of alpha1, alpha2, beta3 and gamma2 subunit mRNAs were altered after the treatment. The immunostainings with antibodies to alpha1, alpha2 and beta3 subunits confirmed the in situ hybridization findings. No neuronal death was detected in any hippocampal subregion in the treated rats. Our results show that status epilepticus disturbs the normal developmental expression pattern of GABAA receptor subunit in the rat hippocampus during the sensitive postnatal period of brain development. These perturbations could result in altered functional and pharmacological properties of GABAA receptors.


Subject(s)
Animals, Newborn/metabolism , Hippocampus/growth & development , Hippocampus/metabolism , RNA, Messenger/metabolism , Receptors, GABA-A/metabolism , Status Epilepticus/metabolism , Aging/metabolism , Animals , Animals, Newborn/growth & development , Fluoresceins , Immunohistochemistry , In Situ Hybridization , Kainic Acid , Organic Chemicals , Phenothiazines , Protein Isoforms/genetics , Protein Isoforms/metabolism , Rats , Rats, Sprague-Dawley , Receptors, GABA-A/genetics , Staining and Labeling , Status Epilepticus/chemically induced
4.
Neuroscience ; 118(4): 967-74, 2003.
Article in English | MEDLINE | ID: mdl-12732242

ABSTRACT

The postnatal expression of GABA(A) receptor subunit mRNAs in the rat brain, including the hippocampus, exhibits a unique temporal and regional developmental profile in vivo, which may be altered by external stimuli. Using the in situ hybridization technique we have now studied the in vitro expression of alpha1,alpha2, alpha 4, alpha 5, beta 1, beta 3, gamma 2, and gamma 3 subunit mRNAs of GABA(A) receptors in organotypic hippocampal slices cultured for 7 days. To find out whether neuronal activity regulates the subunit expression, a subset of cultures was chronically treated either with a GABA(A) receptor antagonist picrotoxin, or by a non-N-methyl-D-aspartate (non-NMDA)-receptor antagonist 6,7-dinitroquinoxaline-2,3-dione (DNQX). In untreated control cultures, the expression pattern of the subunits varied regionally, the most abundantly expressed subunits being alpha 2 and alpha 5 in all subregions. All studied subunits were expressed in CA3a/b and CA1, whereas in CA3c and in granule cells of the dentate gyrus (DG) no signal of alpha 4 and gamma 3 was detected. The drug treatment differently affected the regional subunit expression. In picrotoxin-treated cultures, the expression of alpha1, alpha 5 and gamma 2 mRNAs was significantly increased in pyramidal cell layers, and in DNQX-treated cultures the expression of alpha2 mRNA in CA3c and DG, and that of beta1 in DG. Changes in the expression of GABA(A) receptor subunit mRNAs in treated cultures suggest that neuronal activity can regulate their regional expression in vitro. Since the expression profile in untreated control cultures closely resembled that observed earlier in vivo, organotypic hippocampal slice cultures could serve as a good model system to study the regulatory mechanisms of receptor expression under well-controlled experimental conditions in the developing hippocampus.


Subject(s)
Gene Expression Regulation/drug effects , Hippocampus/metabolism , Neurons/metabolism , Protein Subunits/metabolism , Receptors, GABA-A/metabolism , Animals , Animals, Newborn , Autoradiography/methods , Cell Survival/drug effects , Culture Techniques , Ethanol/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , GABA Antagonists/pharmacology , Hippocampus/anatomy & histology , Hippocampus/drug effects , In Situ Hybridization/methods , Neurons/drug effects , Phenothiazines/metabolism , Picrotoxin/pharmacology , Protein Subunits/analogs & derivatives , Protein Subunits/genetics , Quinoxalines/pharmacology , RNA, Messenger/biosynthesis , Rats , Rats, Wistar , Receptors, GABA-A/genetics
5.
J Neurosci Res ; 66(4): 620-9, 2001 Nov 15.
Article in English | MEDLINE | ID: mdl-11746382

ABSTRACT

Neurofilament (NF) proteins are expressed in the majority of neurons in the central nervous system, and play a crucial role in the organization of neuronal shape and function. In the present study, we have used immunoblotting and immunocytochemical methods to study the light (NF-L), medium (NF-M ), and heavy (NF-H) molecular weight NF proteins in cultured organotypic hippocampal slices during the in vitro maturation and the changes after kainic acid (KA) treatment. In control cultures at 11 DIV throughout 25 DIV, CA3 pyramidal neurons and their proximal dendrites were heavily labeled with the antibodies against all three NF proteins. In CA1 pyramidal neurons, no staining was detected in any age group. A few weakly NF-L positive granule cells with fibers were detected in each age group, whereas NF-M and NF-H positive granule cells first appeared in the older cultures. The application of KA (5 microM) to the cultures for 48 hr, induced a pronounced cell death in the CA3 cell layers, and also moderately damaged granule cells. After the treatment, the immunoblot signal of NF-L and NF-M markedly decreased, whereas that of NF-H almost completely disappeared. The amount of NF-L positive fibers, however, dramatically increased in the molecular and hilar regions of the dentate gyrus in both age groups. Our results show the cellular heterogeneity in the distribution of NF protein triplet in cultured organotypic hippocampal slices. Kainic acid treatment induced changes, which mimicked those observed in the hippocampal region of epileptic animals.


Subject(s)
Aging/physiology , Epilepsy/metabolism , Hippocampus/metabolism , Neurofilament Proteins/metabolism , Neuronal Plasticity/physiology , Pyramidal Cells/metabolism , Aging/drug effects , Animals , Animals, Newborn , Cell Death/drug effects , Cell Death/physiology , Down-Regulation/drug effects , Down-Regulation/physiology , Epilepsy/chemically induced , Epilepsy/pathology , Excitatory Amino Acid Agonists/pharmacology , Hippocampus/growth & development , Hippocampus/pathology , Immunoblotting , Immunohistochemistry , Kainic Acid/pharmacology , Neurofilament Proteins/drug effects , Neuronal Plasticity/drug effects , Neurotoxins/pharmacology , Organ Culture Techniques , Pyramidal Cells/drug effects , Pyramidal Cells/pathology , Rats , Rats, Wistar , Up-Regulation/drug effects , Up-Regulation/physiology
SELECTION OF CITATIONS
SEARCH DETAIL